Treatment of lymphocytic choriomeningitis virus with proteolytic enzymes, hyaluronidase, and phospholipase C increased infectious titres. Biochemical analysis of bromelain-and trypsin-treated virus revealed that infectivity was high in spite of the decrease to low or undetectable levels of all viral glycoproteins as well as partial degradation of the nucleoprotein.
Lymphocytic Choriomeningitis Virus. VII. Structural Alterations of the Virion by Treatment with Proteolytic Enzymes without Loss of Infectivity

By MICHAEL BRUNS AND FRITZ LEHMANN-GRUBE* Heinrich-Pette-lnstitut J~r Experimentelle Virologie und lmmunologie an der Universitiit
Hamburg, Martinistrasse 52, 2000 Hamburg 20, Federal Republic of Germany (Accepted 9 May 1984 SUMMARY Treatment of lymphocytic choriomeningitis virus with proteolytic enzymes, hyaluronidase, and phospholipase C increased infectious titres. Biochemical analysis of bromelain-and trypsin-treated virus revealed that infectivity was high in spite of the decrease to low or undetectable levels of all viral glycoproteins as well as partial degradation of the nucleoprotein.
The infectious titre of lymphocytic choriomeningitis (LCM) virus varies with the assay host, mice being considerably more susceptible than, for instance, L cell cultures (Lehmann-Grube & Hesse, 1967; Gschwender & Lehmann-Grube, 1975 ; F. Lehmann-Grube, unpublished results). One explanation was that infectivity was augmented by some enzyme present in mice but not in L cells as observed for other viruses whose infectivity depends on proteolytic cleavage of certain envelope proteins (Scheid & Choppin, 1974; Klenk et al., 1975) . Treatment of purified LCM virus with proteases, hyaluronidase, and phospholipase C raised the infectious titre. Of numerous experiments with similar results one is presented in Table 1 .
Considering the notorious lability of the infectivity of LCM virus (Lehmann-Grube, 1971) , its resistance to enzymes was quite unexpected. We therefore compared the effect of trypsin and bromelain on LCM virus and vesicular stomatitis virus (VSV) under identical conditions. Whereas trypsin increased the infectious titres of both viruses, bromelain raised the titre of LCM virus but greatly diminished that of VSV (data not shown). Fig. 1 shows the effects of trypsin on proteins of LCM virus. At enzyme concentrations of 1 to 20 mg/ml, two bands became prominent at positions corresponding to apparent molecular weights 38 × 103 and 25 × 103. After incubation of virus with 40 mg/ml trypsin the protein composition was drastically altered and the infectious titre was decreased by more than 99 ~. Treatment of LCM virus with bromelain led to similar results (data not shown). Trypsin also diminished the viral glycoproteins (Fig. 1) . The results of one of several experiments with [aH]glucosamineqabelled virus are presented in Fig. 2 . Incubation with 1 mg/ml trypsin for 30 min at 20 °C reduced the major glycoproteins gp35 and gp44 by approximately 50~o, gp60 by 80 to 90~ and the other glycoproteins as well as the virion-associated mucopolysaccharide by close to 100~o (Fig. 2b ); yet the infectious titre had risen about tenfold. Increasing the enzyme concentration to 20mg/ml resulted in removal of essentially all glucosamine-labelled components, although infectivity was still high (Fig. 2c) . Similar results were obtained by treating [3H]glucosamine-labelled LCM virus with bromelain. In one experiment virus was incubated with l0 mg/ml for 2 h at 37 °C. PAGE of the repurified virus showed that most of the glycoproteins had been removed; there were minimal quantities of gp44 and gp35, and gp130, gp85 and gp60 formed no bands at all. In spite of these alterations the infectious titre was not significantly altered (data not shown). The density of the infectious virus was determined by ultracentrifugation in sucrose and was found to be 1.16 g/ml before and 1.13 to 1.14 g/ml after treatment with bromelain.
Retention of infectivity despite extensive losses of glycoproteins was an unexpected finding, and we suspected that traces resisted enzyme digestion but could not be detected because of 0022-1317/84/0000-6099 $02.00 © 1984 SGM [35S]Methionine-labelled purified virus (Bruns et al., 1983b) was incubated for 30 min at 20 °C with trypsin at concentrations as shown (mg/ml). Virus was repurified and subjected to P A G E under reducing conditions employing slab gels prepared with a 7.5 to 2 0~ acrylamide gradient as described previously (Laemmli, 1970; Bruns et al., 1983b) . Radioactive bands were visualized by fluorography (Bonner & Laskey, 1974) . The infectivities of the samples before disruption of virus for electrophoresis were 3 × 107, 9 x 107, 5 × 107, 3 × 107, 5 × 103 and < 1 × 103 p.f.u./ml, from left to right. 4-6 3-4 2 x 1 0 -2 3.2 2.6 3.0 < 1 × 1 0 2 1.9 1-5 < l x l 0 -2 < l x l 0 -2 0.4 3 x 1 0 -2 2 x 1 0 2 ND~ <1 × I0 2 ND <1 × 10 -2 ND <1 × 10 z ND <1 × 10 -2 ND * The WE strain of LCM virus (Rivers & Scott, 1936 ) was plaque-purified three times. It was propagated in L cells, concentrated from culture fluid by ultracentrifugation, and purified by gradient centrifugation with Urografin (Bruns et al., 1983b) . The virus was assayed on monolayers of L cells (Lehmann-Grube & Ambrassat, 1977) and between 107 and 108 p.f.u, were incubated with enzymes in 1 ml of buffer solution for 30 min at 20 °C (trypsin, chymotrypsin, Pronase O and proteinase K) or for 2 h at 37°C (bromelain, papain, hyaluronidase and phospholipase C). After treatment, virus was repurified.
i" Infectious titre after treatment divided by infectious titre before treatment. [3H]Glucosamine-labelled LCM virus (Bruns et al., 1983b) was incubated for 30 min at 20 °C with 1 mg/ml (b) and 20 mg/ml (c) of enzyme; for the control, virus was incubated in diluent without trypsin (a). After enzyme treatment, virus was repurified and components were separated by PAGE. The resulting autoradiographic bands were quantified by densitometer tracing using the spectral photometer from Zeiss (Oberkochen). The numbered peaks refer to viral constituents: 1, mucopolysaccharide; 2, gp 130; 3, gp85; 4, gp60; 5, gp44; 6, gp35. The small unnumbered peak between nos. 3 and 4 is assumed to represent gp65 of LCM virus interfering particles (Martinez Peralta et al., 1981) . Infectivities before PAGE were 2 × 107, 3 x 108 and 8 x l06 p.f.u./ml for (a), (b) and (c) respectively. insensitivity of the biochemical methods. Confirmation came from neutralization tests (Table 2) showing that the infectivity of enzyme-treated virus was reduced not only by an antiserum directed against all immunogenic viral components, but also by a monoclonal antibody directed against the envelope glycoprotein gp44.
When this work was begun, our interest was centred on the rise of infectious titre of LCM virus after treatment with proteolytic enzymes. The high concentrations required and the observation that different proteinases as well as hyaluronidase and phospholipase had similar effects make specific cleavage of some envelope glycoprotein an unlikely explanation. Electron microscopy of untreated virus always disclosed viral aggregates; these were not seen after enzyme treatment (unpublished results). We think the most plausible explanation for the increase of infectivity is disruption of viral aggregates. Probably, disruption of aggregates also explains the increased neutralizing potential of both anti-LCM virus antiserum and anti-gp44 antibody when titrated against virus incubated with low concentrations of trypsin.
The effect of bromelain on LCM virus has previously been investigated by Buchmeier et al. (1978) who combined the enzyme with the reducing agent dithiothreitol (DTT). Incubation of radioactively labelled and purified virus for 2 h at 37 °C with 4 mg/ml bromelain and 0.01 M-DTT stripped off most of the major glycoproteins GP-1 (= gp44) and GP-2 (= gp35) and at the same time reduced the infectious titre 10000-fold. Essentially the same was observed by us. However, when virus was exposed to bromelain at concentrations as high as 40 mg/ml in the absence of DTT, infectivity remained high, although glycoproteins again disappeared. Since Table 2 . :~ Antiserum directed against all immunogenic components of the LCM virus was prepared in rabbits by inoculating virus passaged once and propagated in primary rabbit kidney ceils which were grown and maintained with MEM and rabbit serum. A monoclonal antibody that is directed against gp44 and neutralizes the LCM virus at high dilution has been described previously (Bruns et al., 1983a) . Virus and immune reagents were appropriately diluted with cell culture medium containing I ktg/ml turkey egg white type II trypsin inhibitor. The mixtures were incubated for 90 rain at 37 °C and residual infectivities were determined by plaque assay. The titre is defined as the reciprocal of the dilution (log~o) of either antiserum or antibody reducing 100 p.f.u, to 50 p.f.u.
Short communication Comparative neutralization of trypsin-treated LCM virus with polyclonal-polyspecific rabbit anti-LCM virus antiserum and monoclonal mouse anti-gp44 antibody
DTT alone reduced viral infectivity, the inactivating effect seen by Buchmeier and his colleagues was probably caused by the reducing agent rather than by the enzyme.
Virus infection begins with adsorption. In the case of enveloped viruses, binding to the cell is thought to involve glycoproteins on the surfaces of both participating entities, and when viruses have spikes, these are assumed to carry the attachment sites (Lonberg-Holm & Philipson, 1974) . PAGE of proteinase-treated but infectious virus always revealed some gp44 and gp35, if only in low quantities. Furthermore, enzyme-treated virus could be neutralized by antibody directed against the envelope glycoprotein gp44. Perhaps the portions of one or more of the glycoproteins that are anchored in the viral envelope resist digestion, as has been shown for other viruses, e.g. Semliki Forest virus (Utermann & Simons, 1974) and VSV (Schloemer & Wagner, 1975) , and allow attachment to cells. This may occur non-specifically, as has been assumed to be the case with bromelain-treated Rous sarcoma virus adsorbing to chicken embryo fibroblasts (Notter et al., 1982) . However, it cannot be excluded that a few spikes remain fully intact and mediate both adsorption and neutralization, although there is one observation suggesting structural alterations of viral glycoproteins. Both immune reagents reduced the infectivity of untreated virus and of virus treated with low quantities of trypsin. However, raising the concentration of the enzyme with which the virus was incubated to levels at which the infectious titre was just beginning to be affected led to a reduction of the neutralizing potential, especially that of the monoclonal antibody. We assume that this effect results from some alteration of viral epitopes causing reduced strength of binding with the antibody molecules.
The proteolytic changes caused by exposure of LCM virus to bromelain and trypsin were so extensive as to suggest that there were other alterations. However, the density of the infectious virus was only slightly decreased. The electron microscopic image of the virion was not grossly altered, although spikes were never seen (our unpublished observations). Since proteolytic treatment of LCM virus does not demonstrably affect its RNA (our unpublished observations), there is no difficulty accepting the finding that infection proceeds normally provided adsorption has occurred. The partial fragmentation of p63 is obviously irrelevant in this respect, which is perhaps not surprising because subunits of the nucleoprotein are also found in virus not experimentally exposed to proteinases, although in lower quantities (Bruns et al., 1983 b; Bruns & Lehmann-Grube, 1983 ).
The Heinrich-Pette-Institut is financially supported by Freie und Hansestadt Hamburg and Bundesministerium ffir Jugend, Familie und Gesundheit, This work was supported by a grant from the Deutsche Forschungsgemeinschaft.
